Valuation: West Pharmaceutical Services, Inc.

Market Cap 26.07B 22.88B 21.61B 19.69B 36.86B 2,499B 37.12B 259B 100B 1,277B 97.88B 95.77B 4,103B P/E 2026 *
43.2x
P/E 2027 * 37.6x
Enterprise Value 25.57B 22.43B 21.19B 19.31B 36.15B 2,450B 36.4B 254B 98.21B 1,252B 95.99B 93.92B 4,023B EV / Sales 2026 *
7.58x
EV / Sales 2027 * 7x
Free-Float
92.88%
Yield 2026 *
0.24%
Yield 2027 * 0.26%
1 day-0.76%
1 week+3.68%
Current month+11.69%
1 month+8.43%
3 months+10.14%
1 week 299.58
Extreme 299.579
310.36
1 month 270.08
Extreme 270.0785
310.36
Current year 253.33
Extreme 253.329
310.36
1 year 253.33
Extreme 253.329
310.36
3 years 253.33
Extreme 253.329
310.36
5 years 253.33
Extreme 253.329
310.36
10 years 253.33
Extreme 253.329
310.36
Manager TitleAgeSince
Chief Executive Officer 52 31/08/2026
Director of Finance/CFO 57 04/08/2025
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Director/Board Member 65 01/02/2011
Director/Board Member 69 07/03/2011
Director/Board Member 56 12/02/2012
Change 5-day change 1-year change 3-year change Capi.($)
-0.76%+3.68% - - 26.07B
+0.22%-1.29%-24.16%+5.26% 175B
+0.97%-3.79%-5.92%+12.27% 113B
-0.95%-0.60%-0.03%+65.22% 58.57B
+2.56%+1.59%-0.42%-29.55% 50.07B
+1.49%+3.89%+15.12%+53.65% 49.92B
-0.97%-3.06%+29.09%-2.26% 32.69B
+0.12%+9.67% - - 30.44B
-0.85%+2.24%+41.65%-1.32% 26.07B
-1.58%+7.22%+23.81%-6.14% 23.55B
Average +0.03%+1.73%+9.89%+12.14% 62.22B
Weighted average by Cap. +0.32%-0.01%-2.98%+13.37%

Financials

2026 *2027 *
Net sales 3.37B 2.96B 2.8B 2.55B 4.77B 323B 4.8B 33.46B 12.96B 165B 12.67B 12.39B 531B 3.59B 3.15B 2.97B 2.71B 5.07B 344B 5.11B 35.57B 13.78B 176B 13.47B 13.18B 564B
Net income 617M 542M 512M 466M 873M 59.18B 879M 6.12B 2.37B 30.23B 2.32B 2.27B 97.16B 703M 617M 582M 531M 993M 67.34B 1B 6.97B 2.7B 34.4B 2.64B 2.58B 111B
Net Debt -503M -442M -417M -380M -712M -48.24B -717M -4.99B -1.93B -24.64B -1.89B -1.85B -79.2B -973M -854M -807M -735M -1.38B -93.3B -1.39B -9.65B -3.74B -47.67B -3.66B -3.58B -153B
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and administration of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by group of products as follows: - proprietary products (81.1%); - contract-manufactured products (18.9%). At the end of 2025, the group had 25 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (43.2%), Germany (12.4%), Ireland (10.8%), France (7.4%), Europe (14.7%) and other (11.5%).
Employees
10,800
Date Price Change
25/09/26 CHF 308.02 -0.76%
24/09/26 CHF 310.36 +1.60%
23/09/26 CHF 305.46 -0.67%
22/09/26 CHF 307.51 +2.65%
21/09/26 CHF 299.58 +0.84%
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
370.44USD
Average target price
407.56USD
Spread / Average Target
+10.02%

Quarterly revenue - Rate of surprise